Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStaying well hydrated on Mounjaro matters more than most people expect. Clinical trial data from the SURMOUNT programme consistently recorded gastrointestinal side effects — nausea, vomiting, diarrhoea — as the most common adverse events, and each of those can quietly chip away at your fluid balance before you notice. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber will assess whether it is clinically suitable for you before any treatment begins. But if you are already on treatment or considering it, understanding how tirzepatide affects your hydration is practical, genuinely useful information, and the full picture on Mounjaro as a treatment gives you the broader context.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity and tracked them for 72 weeks. Nausea affected around 30–45% of participants across dose groups, and diarrhoea was reported by roughly a quarter. These aren't trivial numbers. Each episode is a small fluid loss; string several together during a dose increase and the deficit adds up. The NHS tirzepatide patient information explicitly flags dehydration and its effect on kidney function as reasons to contact a healthcare professional without delay, not something to sleep on.
Tirzepatide also slows the rate at which the stomach empties. That's central to how it reduces appetite, but it has a secondary effect: many people feel full on much smaller amounts of food and, alongside that, find they are simply less interested in drinking. Thirst and hunger travel in similar channels behaviourally. When your appetite is suppressed, the impulse to reach for a glass of water can fall away with it. That's not a side effect listed in the leaflet, but it's a pattern prescribers observe consistently.
The practical upshot is that you can't rely on thirst alone to guide your intake on tirzepatide. A proactive approach works better, and the urine-colour test mentioned above is the simplest one available. Pale straw is fine. Dark amber is a signal. That check costs you nothing and takes no equipment.
There is no single number that works for everyone. NHS guidance on healthy hydration points to roughly 6–8 glasses (around 1.5–2 litres) of fluid daily for most adults in the UK, adjusted upward for heat, exercise and illness. On tirzepatide, that baseline becomes a floor rather than a ceiling, particularly during the first weeks of a new dose when GI symptoms tend to peak. If you are having repeated episodes of vomiting or diarrhoea, plain water alone may not be enough, electrolytes (sodium, potassium, magnesium) are lost alongside fluid, and replenishing them matters. A pharmacist or your prescriber can advise on the most appropriate approach for your circumstances.
Plain water is the obvious starting point, but it doesn't have to be the only one. Herbal teas, diluted squash and the water content of foods (soups, fruit, vegetables) all contribute. Coffee and alcohol are worth moderating: both have mild diuretic effects, and the reduced portion sizes typical of tirzepatide treatment mean some people find their caffeine tolerance shifts too. Sipping steadily through the day tends to work better than drinking large amounts in one go, especially if nausea is present.
People who want to understand the specific mechanisms around tirzepatide and fluid can read more on how Mounjaro and water interact at a physiological level. The context there is useful if you're trying to make sense of symptoms rather than just manage them.
Mild nausea that settles within a day or two is common, especially after a dose increase. Persistent vomiting, very frequent loose stools or an inability to keep fluids down for more than 24 hours is a different matter. The Mounjaro prescribing information and the NHS medicine page for tirzepatide both identify signs of dehydration (dizziness, reduced urination, rapid heartbeat, confusion) as reasons to seek prompt medical help. Kidney injury from severe dehydration, though uncommon, is a recognised risk with GLP-1 and dual-agonist medicines.
It's also worth knowing that any changes to other medicines you take (particularly those that affect kidney function or blood pressure) should be discussed with your prescriber if your fluid intake drops significantly. Blood pressure medicines and diuretics are the most common examples. This isn't something to navigate alone; that's exactly the kind of nuanced question that belongs in a clinical conversation. Our team is available seven days a week through priority aftercare if questions arise between reviews.
One related concern that comes up often is the question of urinary symptoms during treatment. If you're experiencing anything in that area, the page on Mounjaro and water infections covers what is and isn't known. Separately, some people notice changes in how their body holds on to water, that question is addressed on Mounjaro and water retention, which is a distinct issue from hydration but equally worth understanding.
Mounjaro is a prescription-only medicine, and the clinical oversight around it exists for good reason. Hydration is one of the more manageable aspects of treatment when you know what to watch for, but it's one piece of a broader clinical picture that a prescriber needs to hold together. Dose titration, other medicines, your activity level, any underlying kidney or heart conditions: all of these influence how you should approach fluid intake on tirzepatide.
If you're considering treatment and want to understand costs as part of your decision, the Mounjaro cost page explains what private treatment involves. And if you're curious about tirzepatide more broadly before committing to a consultation, our tirzepatide overview covers the licensed evidence base. When you're ready to speak to one of our GPhC-registered prescribers (a real clinician, not automated software) start your free consultation and they'll review your situation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.